Language

CAS No. 863127-77-9 | Dasatinib monohydrate

CAS No. 863127-77-9 | Dasatinib monohydrate

Name: Dasatinib monohydrate CAS No. 863127-77-9 MF:C22H28ClN7O3S MW:506.02 Purity:98% Package: 5g,25g,200g,500g,1kg Worldwide Delivery

Categories：

Biochemicals

Email：sale06@alfachem.cn

Inquiry

Chat Now

Product introduction

Introduction and application of CAS No. 863127-77-9 | Dasatinib monohydrate

Synonyms:DasatinibR;BMS-354825Monohydrate;

N-(2-chloro-6-methylphenyl)-2-(6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-ylamino)thiazole-5-carboxamidehydrate;

DasatinibmonohydrateN-(2-Chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)-1-piperazinyl]-2-methyl-4-pyrimidinyl]amino]-5-thiazolecarboxamidemonohydrate;

Dasatinibmonohydrate;

dasatinibmonohydrate;

5-Thiazolecarboxamide,N-(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)-1-piperazinyl]-2-methyl-4-pyrimidinyl]amino]-,hydrate;

Dasatinib(TINIBS)

Specification:

ITEMS	SPECIFICATION
CAS	863127-77-9
MF	C22H28ClN7O3S
MW	506.02
Melting point	>223°
Color	White to off white
Solubility	Soluble in DMSO (slight sonication), methanol (slight sonication)
Form	Solid
Storage condition	Keep in dark place,Sealed in dry,Store in freezer, under -20°C

Introduction:

Dasatinib, also known as DASA tin IB, is a gray to yellow solid chemical. Dasatinib is an anti-tumor drug. It is clinically mainly used to treat Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML) that is resistant to or intolerant to imatinib mesylate in the chronic phase, accelerated phase and blast phase. (acute myeloidosis and acute lymphadenitis) in adult patients.

use:

Dasatinib is used for all stages of chronic myeloid leukemia (chronic phase, accelerated phase, lymphoid blast phase and myeloid cell blast phase) that have been treated, including imatinib mesylate/Gleevec (Imatinibmesylate/Gleevec) resistance or intolerance. Adult patients in blast phase). At the same time, the FDA also approved dasatinib through normal procedures for the treatment of adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia who are resistant or intolerant to other therapies.

Package and transportation :

Package: 5g,25g,200g,500g,1kg